BiotechTube
Home/Altimmune/Cynthia L. Bens
CL

Cynthia L. Bens

Senior Vice President, Investor Relations & Corporate Communications

Altimmune

Therapeutic Areas

ObesityMetabolic DiseasesLiver DiseasesMASH/NASH

Altimmune Pipeline

DrugIndicationPhase
Pemvidutide (ALT-801)ObesityPhase 2
HepTcellChronic Hepatitis BPhase 2
NasoVAXInfluenzaPhase 2

Leadership Team at Altimmune

VK
Vipin K. Garg, Ph.D.
President, Chief Executive Officer, and Director
RE
Richard Eisenstadt
Chief Financial Officer
SH
Scott Harris, M.D.
Chief Medical Officer
R(
Raymond (Ray) T. Jones
Senior Vice President, Commercial
DJ
Dr. John B. Bode, J.D.
Senior Vice President, Corporate Development & General Counsel
E(
Elizabeth (Bess) G. Weatherman
Chairman of the Board of Directors
DT
Dr. Timothy D. Barberich
Director
DW
Dr. William (Bill) J. Enright
Director
DJ
Dr. John P. Richard
Director
DC
Dr. Caroline Loew, Ph.D.
Director
View full Altimmune profile